{"id":"https://openalex.org/W1867320293","doi":null,"title":"Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.","display_name":"Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.","publication_year":2005,"publication_date":"2005-07-01","ids":{"openalex":"https://openalex.org/W1867320293","mag":"1867320293","pmid":"https://pubmed.ncbi.nlm.nih.gov/16080512"},"language":"en","primary_location":{"id":"pmid:16080512","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16080512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017439042","display_name":"Orlando Ghirardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131844","display_name":"Sigma Tau (Italy)","ror":"https://ror.org/03bxtpd68","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210131844"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Orlando Ghirardi","raw_affiliation_strings":["Research and Development, Sigma-Tau S.p.A. Industrie Farmaceutiche Riunite, Rome, Italy. orlando.ghirardi@sigma-tau.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development, Sigma-Tau S.p.A. Industrie Farmaceutiche Riunite, Rome, Italy. orlando.ghirardi@sigma-tau.it","institution_ids":["https://openalex.org/I4210131844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057782494","display_name":"Pietro Lo Giudice","orcid":"https://orcid.org/0000-0002-5843-0017","observed_orcids":["https://orcid.org/0000-0002-5843-0017"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pietro Lo Giudice","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045670524","display_name":"Claudio Pisano","orcid":"https://orcid.org/0000-0001-8624-2980","observed_orcids":["https://orcid.org/0000-0001-8624-2980"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Pisano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052247594","display_name":"Mario Vertechy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Vertechy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111497823","display_name":"Augusta Bellucci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Augusta Bellucci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019273560","display_name":"Loredana Vesci","orcid":"https://orcid.org/0009-0008-0110-0106","observed_orcids":["https://orcid.org/0009-0008-0110-0106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Loredana Vesci","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033860204","display_name":"Sante Cundari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sante Cundari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057423932","display_name":"Mariarosaria Miloso","orcid":"https://orcid.org/0000-0002-6971-5827","observed_orcids":["https://orcid.org/0000-0002-6971-5827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mariarosaria Miloso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108376753","display_name":"Laura Maria Rigamonti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Maria Rigamonti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063639567","display_name":"Gabriella Nicolini","orcid":"https://orcid.org/0000-0002-6241-4538","observed_orcids":["https://orcid.org/0000-0002-6241-4538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriella Nicolini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084431593","display_name":"Claudio Zanna","orcid":"https://orcid.org/0009-0001-8001-2065","observed_orcids":["https://orcid.org/0009-0001-8001-2065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Zanna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5107658386","display_name":"Paolo Carminati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paolo Carminati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2737,"has_fulltext":false,"cited_by_count":76,"citation_normalized_percentile":{"value":0.91705838,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"25","issue":"4","first_page":"2681","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acetyl-l-carnitine","display_name":"acetyl-L-carnitine","score":0.9459999799728394},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.7730000019073486},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7960000038146973},{"id":"https://openalex.org/keywords/chemotherapy-induced-neurotoxicity","display_name":"chemotherapy-induced neurotoxicity","score":0.8920000195503235},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9269999861717224},{"id":"https://openalex.org/keywords/neuroprotective-agents","display_name":"neuroprotective agents","score":0.5789999961853027},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.9236865043640137},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7880406379699707},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.7683209180831909},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.7139238715171814},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7109947204589844},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.682250440120697},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.625201940536499},{"id":"https://openalex.org/C2778435403","wikidata":"https://www.wikidata.org/wiki/Q243309","display_name":"Carnitine","level":2,"score":0.5273236632347107},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.4183218777179718},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4141075313091278},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3484099805355072},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26050227880477905},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26036888360977173},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2507156431674957},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.23265200853347778},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11693546175956726},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11131694912910461},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.05996406078338623},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000108","descriptor_name":"Acetylcarnitine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010523","descriptor_name":"Peripheral Nervous System Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019073","descriptor_name":"HT29 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmid:16080512","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16080512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"pmh:oai:boa.unimib.it:10281/1013","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/10281/1013","pdf_url":null,"source":{"id":"https://openalex.org/S4306401259","display_name":"BOA (University of Milano-Bicocca)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"mag:1867320293","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16080512","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W40275277","https://openalex.org/W90845095","https://openalex.org/W1481043761","https://openalex.org/W1968710650","https://openalex.org/W1971045589","https://openalex.org/W1990512833","https://openalex.org/W1994422014","https://openalex.org/W2003917823","https://openalex.org/W2004637463","https://openalex.org/W2031449019","https://openalex.org/W2033465919","https://openalex.org/W2039833606","https://openalex.org/W2044132291","https://openalex.org/W2051071188","https://openalex.org/W2072068594","https://openalex.org/W2087401864","https://openalex.org/W2092617973","https://openalex.org/W2102083512","https://openalex.org/W2102674981","https://openalex.org/W2107887908","https://openalex.org/W2109689528","https://openalex.org/W2147086910","https://openalex.org/W2162313061","https://openalex.org/W2444048247","https://openalex.org/W4390927988"],"related_works":["https://openalex.org/W6987448377","https://openalex.org/W2107887908","https://openalex.org/W2376175914","https://openalex.org/W81527160","https://openalex.org/W2142361483","https://openalex.org/W2155821409","https://openalex.org/W2002418060","https://openalex.org/W102427289","https://openalex.org/W2047955445","https://openalex.org/W2083741086"],"abstract_inverted_index":{"BACKGROUND:":[0],"Oxaliplatin":[1],"(OHP)":[2],"is":[3,126],"severely":[4],"neurotoxic":[5],"and":[6,47,62,78,131],"induces":[7],"the":[8,48,85,94,119,129],"onset":[9],"of":[10,50,87,122,133],"a":[11,18,31],"disabling":[12],"sensory":[13],"peripheral":[14,136],"neuropathy.":[15,36],"Acetyl-L-carnitine":[16],"(ALC),":[17],"natural":[19],"compound":[20],"with":[21,56,118],"neuroprotective":[22],"action,":[23],"was":[24,42,58,72,91,100],"tested":[25],"to":[26],"determine":[27],"whether":[28],"it":[29,90],"plays":[30],"protective":[32],"role":[33],"in":[34,44,54,76,79,108,128,138],"OHP-induced":[35,98,135],"MATERIALS":[37],"AND":[38],"METHODS:":[39],"Peripheral":[40],"neuropathy":[41,99],"induced":[43],"Wistar":[45],"rats,":[46],"effect":[49],"OHP":[51,69,88],"alone":[52],"or":[53],"combination":[55],"ALC":[57,66,114,125],"assessed,":[59],"using":[60,74],"behavioral":[61],"neurophysiological":[63],"methods.":[64],"Moreover,":[65],"interference":[67],"on":[68],"antitumor":[70,120],"activity":[71],"investigated":[73],"several":[75],"vitro":[77],"vivo":[80],"models.":[81],"RESULTS:":[82],"ALC-co-treatment":[83],"reduced":[84],"neurotoxicity":[86,137],"when":[89],"coadministered.":[92],"Furthermore,":[93],"administration-of":[95],"OHP,":[96],"once":[97],"established,":[101],"significantly":[102],"mitigated":[103],"its":[104],"severity.":[105],"Finally,":[106],"experiments":[107],"different":[109],"tumor":[110],"systems":[111],"indicated":[112],"that":[113],"does":[115],"not":[116],"interfere":[117],"effects":[121],"OHP.":[123],"CONCLUSION:":[124],"effective":[127],"prevention":[130],"treatment":[132],"chronic":[134],"an":[139],"experimental":[140],"rat":[141],"model.":[142]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}